WNT5B is overexpressed in the majority of Triple Negative (TNBC)/Basal-Like Breast Cancer (BLBC) cell lines and primary patient samples and is correlated with a worse prognosis (Yang et al., 2014; Jiang et al., 2019). Here, WNT5B is linked to breast carcinoma.